UK Markets closed

Invacare Corporation (IVC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.6800+0.0200 (+0.43%)
At close: 4:00PM EDT
4.6800 -0.01 (-0.11%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.87
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 310.9400
52-week low 34.0800
50-day moving average 35.4617
200-day moving average 37.4635

Share statistics

Avg vol (3-month) 3680.92k
Avg vol (10-day) 3610.39k
Shares outstanding 534.95M
Implied shares outstanding 6N/A
Float 829.12M
% held by insiders 15.68%
% held by institutions 1123.07%
Shares short (14 Sept 2021) 48.61M
Short ratio (14 Sept 2021) 412.68
Short % of float (14 Sept 2021) 430.58%
Short % of shares outstanding (14 Sept 2021) 424.60%
Shares short (prior month 12 Aug 2021) 49.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Apr 2020
Ex-dividend date 401 Apr 2020
Last split factor 22:1
Last split date 316 Oct 1995

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -4.33%
Operating margin (ttm)0.01%

Management effectiveness

Return on assets (ttm)0.01%
Return on equity (ttm)-12.74%

Income statement

Revenue (ttm)858.01M
Revenue per share (ttm)24.82
Quarterly revenue growth (yoy)15.10%
Gross profit (ttm)245.25M
Net income avi to common (ttm)-37.13M
Diluted EPS (ttm)-1.2560
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)78.25M
Total cash per share (mrq)2.23
Total debt (mrq)398.29M
Total debt/equity (mrq)141.80
Current ratio (mrq)1.57
Book value per share (mrq)8.12

Cash flow statement

Operating cash flow (ttm)-10.81M
Levered free cash flow (ttm)-6.9M